3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
8
Breast Neoplasms
7
Prostatic Neoplasms
6
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Urinary Bladder Neoplasms
5
Glioma
5
Astrocytoma
5
Oropharyngeal Neoplasms
4
Esophageal Neoplasms
4
Carcinoma
4
Burkitt Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Rectal Neoplasms
3
Neoplasm Metastasis
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Liposarcoma
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Interventions
ribociclib
2
Specimen Handling
2
tucatinib
1
trastuzumab biosimilar HLX02
1
pertuzumab
1
pembrolizumab
1
exemestane
1
durvalumab
1
Watchful Waiting
1
Trastuzumab
1
Taxes
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Observation
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Immunoglobulin G
1
Genetic Testing
1
Fulvestrant
1
Drug Therapy
1
Doxorubicin
1
Docetaxel
1
Disulfides
1
Cyclophosphamide
1
Carboplatin
1
Biopsy
1
Anastrozole
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage II Breast Cancer AJCC v8
×
Radiation
×
30 days
×
Clear all
No trials found.